ArticleExperimental hematology & oncology2019

A high-throughput screening identifies histone deacetylase inhibitors as therapeutic agents against medulloblastoma.

Shanshan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.